Lexicon Pharmaceuticals Inc
LXRX
Get informed when a big investor buys or sells
+ FollowMarket Cap$676.33M
Close$
$-0.39
125.8% downside
Current Fair Value
125.8% downsideOvervalued by 125.8% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $676.33 Million |
|---|---|
| Enterprise Value | $635.41 Million |
| Dividend Yield | $- (-) |
| Earnings per Share | $-0.14 |
| Beta | 1.08 |
| Outstanding Shares | 437,653,000 |
Return
| Return on Equity | -35.02% |
|---|---|
| Return on Assets | -24.44% |
| Return on Invested Capital | -24.27% |
Valuation & Multiples
| P/E Ratio | -10.11 |
|---|---|
| PEG | 0.94 |
| Price to Sales | - |
| Price to Book Ratio | - |
| Enterprise Value to Revenue | 15.32 |
| Enterprise Value to EBIT | -11.12 |
| Enterprise Value to Net Income | -11 |
| Total Debt to Enterprise | 0 |
| Debt to Equity | 0 |
Revenue Sources
No data
Insider Trades
Last Earnings Call
Report Date
August 6, 2026
EPS Estimate
$-0.05
Average shareholder expectationRevenue Estimate
$3.99 M
Average shareholder expectationNext Earnings Call
Expected Date
November 5, 2026
EPS Estimate
$-0.06
Average shareholder expectationRevenue Estimate
$4.14 M
Average shareholder expectationInstitutional Put/Call Ratio
Market sentiment based on institutional option activity.
| Put/Call Ratio | 0.0000▼ 2.21% |
|---|---|
| Total Calls | -▼ 100.00% |
| Total Puts | -▼ 100.00% |
Institutional Ownership
Holdings and activity of institutional investors.
| Ownership % | 0.00%▼ 91.59% |
|---|---|
| Total Invested | $2,083▼ 100.00% |
| Investors Holding | 3▼ 153.00% |
ESG Score
No data